DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
企業コードDRIO
会社名DarioHealth Corp
上場日Mar 08, 2013
最高経営責任者「CEO」Mr. Erez Raphael
従業員数196
証券種類Ordinary Share
決算期末Mar 08
本社所在地322 W 57Th St. #33B
都市NEW YORK
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号10019
電話番号16466654667
ウェブサイトhttps://shop.mydario.com/
企業コードDRIO
上場日Mar 08, 2013
最高経営責任者「CEO」Mr. Erez Raphael
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし